Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Low-Dose Intravenous Ketamine for Primary Pain Control During Naxitamab Anti-GD2 Immunotherapy Treatment.
Journal: Pediatric blood & cancer
Published: January 06, 2026
Utilization of integrative medicine differs by age among pediatric oncology patients.
Journal: Pediatric blood & cancer
Published: November 12, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026